Common drug may shield hearts during breast cancer radiation
NCT ID NCT05607017
First seen Apr 17, 2026 · Last updated May 16, 2026 · Updated 2 times
Summary
This small early-phase study tested whether losartan, a common blood pressure medication, could prevent early signs of heart damage caused by radiation therapy in breast cancer patients. Five women with left-sided breast cancer who were scheduled for standard radiation took losartan. The study measured heart changes using MRI scans and blood tests to see if the drug could reduce radiation-induced fibrosis.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Massachusetts General Hospital Cancer Center
Boston, Massachusetts, 02114, United States
Conditions
Explore the condition pages connected to this study.